• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Antonio Iavarone, M.D., has made a decades-long commitment to finding better treatments for glioblastoma and other aggressive brain tumors. As the new deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, he will have opportunities to do even more.

• share
• favorite_border

New research led by researchers at the University of Miami Miller School of Medicine and published in the Journal of Hepatology, suggests that getting a third dose of the COVID-19 mRNA vaccine could overcome the decreased vaccine respons in cirrhosis patients and offer strong protection against the virus, severe illness, and death from COVID-19.

• share
• favorite_border

Researchers at the Miller School are looking for solutions to the continued effects of alcohol use, its harmful impact, and treatment. Understanding the mechanisms of alcohol abuse has gained importance, especially after the COVID-19 pandemic. Higher alcohol consumption led to an increased burden of pancreatic diseases in society.

• share
• favorite_border

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that they can circumvent a key mechanism in castration-resistant prostate cancer (CRPC) and possibly make immunotherapies more effective. By infusing nitric oxide (NO) into animal models, the team shrank tumors and paved the way for potential combination therapies. The study was published in Nature Cell Death & Disease.

• share
• favorite_border

Researchers at the University of Miami Miller School of Medicine collaborated on a recently published paper that provides new guidance on inclusion of underrepresented populations in genetics research.

• share
• favorite_border

A team of researchers at the University of Miami Miller School of Medicine have uncovered a potential approach for treating patients with serious long-term COVID conditions. In two recent studies using experimental models, they found that placing a peptide “net” around the spike protein on the virus reduced deaths from organ failure and improved overall outcomes.

• share
• favorite_border

• share
• favorite_border

The Desai Sethi Urology Institute at the University of Miami Miller School of Medicine will be hosting urology clinicians and scientists from today’s most prominent academic centers at the institute’s inaugural in-person "Urology on the Beach" meeting, January 13 to 15, 2023, at the Fontainebleau Hotel in Miami Beach.

• share
• favorite_border

In an article published in The Lancet Neurology, Girardin Jean-Louis, Ph.D., of the University of Miami Health System, addresses how sleep disparities may impact health in minority communities. People in these groups face higher risks of cardiovascular disease, diabetes, high blood pressure, and other chronic conditions. Lack of sleep may help drive these disparities.

• share
• favorite_border

The University of Miami Miller School of Medicine has received a U.S. patent for a device that diagnoses mild traumatic brain injury and concussion at the point of care.

• share
• favorite_border

The University of Miami Miller School of Medicine and UHealth – University of Miami Health System have signed a memorandum of understanding (MOU) with Jamaica’s minister of health to improve the health infrastructure in Jamaica and the Caribbean through education and collaboration.

• share
• favorite_border

The National Institute on Deafness and Other Communication Disorders (NIDCD) has awarded Xue Zhong Liu, M.D., Ph.D., Marian and Walter Hotchkiss Endowed Chair in Otolaryngology at the University of Miami Miller School of Medicine, a five-year, $3.5 million R01 research grant to develop a precision medicine approach to treat hearing loss (HL) in Usher syndrome (USH).

• share
• favorite_border

• share
• favorite_border

“Dr. Welford works closely with both basic science and clinical investigators to understand the biology of cancer and develop new therapies that will lead to better clinical outcomes. His excellence in translational research is founded on strong basic science discoveries,” Dr. El-Rifai said.

• share
• favorite_border

Azizi Seixas, Ph.D., founding director of the Media and Innovation Lab (The MIL) at the University of Miami Miller School of Medicine, has been chosen by Amazon Web Services (AWS) as one of 10 U.S. Education Champions. The inaugural program showcases innovators driving digital transformation with cloud computing in the areas of teaching, learning, research, and academic medicine. AWS recognized Dr. Seixas and his fellow honorees at the IMAGINE 2022 conference in Seattle in August.

• share
• favorite_border

The University of Miami Miller School of Medicine Division of Digestive Health and Liver Diseases shines not only for its commitment to patient care and published research, but also as a beacon for advancing the careers of female physicians. The division is celebrating the latter during September, which is the American Medical Association’s National Women in Medicine Month.

• share
• favorite_border

Sylvester Comprehensive Cancer Center researcher Emmanuel Thomas, M.D., Ph.D., F.A.A.S.L.D., has been appointed to the National Institutes of Health’s (NIH) Coinfections and HIV Associated Cancers (HCAC) study section.

• share
• favorite_border

Ashish Shah, M.D., has assumed the newly created position of director of clinical trials and translational research and principal investigator in the Section of Virology and Immunotherapy at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative (BTI) at the University of Miami Miller School of Medicine. Dr. Shah, who calls himself a “quadruple ’Cane,” returns to the site of his undergraduate studies, medical school, and residency as a faculty member. This follows a year-long fellowship at the National Institutes of Health, where he focused on clinical trial design and translational neuro-oncology.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

To build a resource that greatly expands Alzheimer’s disease genetic studies in the currently underrepresented African ancestry populations and Hispanic/Latinx groups, the John P. Hussman Institute for Human Genomics (HIHG) at the University of Miami Miller School of Medicine will lead a major five-year, international, multi-site initiative with Case Western Reserve University, Columbia University, Wake Forest University, the University of Pennsylvania, and the University of Ibadan, which is the lead institution for the African Dementia Consortium (AfDC).

• share
• favorite_border

• share
• favorite_border

South Florida counties have above-average rates of mortality from gastric cancer, according to a new study published in the journal Gastroenterology by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

• share
• favorite_border

Researchers at the John T. Macdonald Department of Human Genetics and John P. Hussman Institute for Human Genomics at the University of Miami Miller School of Medicine have found that inherited mutations in the MINAR2 gene caused deafness in four families. The gene variation mostly affects the inner ear hair cells, which are critical to hearing. The authors believe the progressive nature of this hearing loss, in some affected individuals and in mice, could offer opportunities for treatment.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Sylvester Comprehensive Cancer Center is making another bold move to accelerate cancer research, celebrating the groundbreaking for a 244,000-square-foot, state-of-the-art Sylvester Comprehensive Cancer Center - Transformational Cancer Research Building (TCRB).

• share
• favorite_border

A University of Miami Miller School of Medicine researcher is hoping an innovative multicenter clinical trial will lead to new therapies for neurofibromatosis type 2 (NF2), a devastating disease causing multiple types of tumors involving the brain, spine, and peripheral nerves.

• share
• favorite_border

Sylvester Comprehensive Cancer Center’s Rectal Cancer Program has earned a three-year accreditation from the American College of Surgeons’ National Accreditation Program for Rectal Cancer (NAPRC). The program is one of only around 50 in the country, and the first in Miami, to gain this recognition.

• share
• favorite_border

A national policy change to facilitate the broader sharing of donor livers through “acuity circles” has resulted in procurement delays, according to a researcher at the University of Miami Miller School of Medicine.

• share
• favorite_border

• share
• favorite_border

Long COVID-19 syndrome, in which symptoms last a year or longer beyond infection, impacts about 30 percent of survivors of the coronavirus. Lina Shehadeh, Ph.D., professor of medicine in the Interdisciplinary Stem Cell Institute and Division of Cardiology at the University of Miami Miller School of Medicine, received a $1 million grant from the American Heart Association to study long COVID.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

In a research letter to the journal JAMA Oncology, clinical researchers at Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine showed that immunotherapy can be an option for at least one subgroup of pancreatic cancer patients. The study found that patients with inherited BRCA and other similar mutations can achieve complete responses — in some cases going from near death to durable recoveries.

• share
• favorite_border

Inadequate genomic data on Black women with metastatic breast cancer reduces their access to targeted therapies